Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb;44(2):259-267.
doi: 10.1038/s41401-022-00935-1. Epub 2022 Jun 17.

Channelopathy of small- and intermediate-conductance Ca2+-activated K+ channels

Affiliations
Review

Channelopathy of small- and intermediate-conductance Ca2+-activated K+ channels

Young-Woo Nam et al. Acta Pharmacol Sin. 2023 Feb.

Abstract

Small- and intermediate-conductance Ca2+-activated K+ (KCa2.x/KCa3.1 also called SK/IK) channels are gated exclusively by intracellular Ca2+. The Ca2+ binding protein calmodulin confers sub-micromolar Ca2+ sensitivity to the channel-calmodulin complex. The calmodulin C-lobe is constitutively associated with the proximal C-terminus of the channel. Interactions between calmodulin N-lobe and the channel S4-S5 linker are Ca2+-dependent, which subsequently trigger conformational changes in the channel pore and open the gate. KCNN genes encode four subtypes, including KCNN1 for KCa2.1 (SK1), KCNN2 for KCa2.2 (SK2), KCNN3 for KCa2.3 (SK3), and KCNN4 for KCa3.1 (IK). The three KCa2.x channel subtypes are expressed in the central nervous system and the heart. The KCa3.1 subtype is expressed in the erythrocytes and the lymphocytes, among other peripheral tissues. The impact of dysfunctional KCa2.x/KCa3.1 channels on human health has not been well documented. Human loss-of-function KCa2.2 mutations have been linked with neurodevelopmental disorders. Human gain-of-function mutations that increase the apparent Ca2+ sensitivity of KCa2.3 and KCa3.1 channels have been associated with Zimmermann-Laband syndrome and hereditary xerocytosis, respectively. This review article discusses the physiological significance of KCa2.x/KCa3.1 channels, the pathophysiology of the diseases linked with KCa2.x/KCa3.1 mutations, the structure-function relationship of the mutant KCa2.x/KCa3.1 channels, and potential pharmacological therapeutics for the KCa2.x/KCa3.1 channelopathy.

Keywords: KCa2.2 channels; KCa2.3 channels; KCa3.1 channels; Zimmermann-Laband syndrome; channelopathy; hereditary xerocytosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. KCa2.2 channel structure and LOF mutations.
a Human KCa2.2 channel homology model generated using human KCa3.1 channel (PDB: 6cnn) as a template. Pore-forming channel α-subunits are shown in salmon and its accessory CaM is shown in gray. Mutations are shown as spheres with carbon atoms in green, oxygen atoms in red, and nitrogen atoms in dark blue. Mutations in only one of the four α-subunits are shown for clarity. In the inset, the relative position of CaM N-lobe, the S4-S5 linker (S45A and S45B helices), and HA helix is shown. b Mutations in selectivity filter and transmembrane S6 domain of channel pore. Mutations in only one of two opposite α-subunits are shown for clarity. c Schematic representation of one KCa2.2 channel subunit. Pathogenic LOF mutations are shown as green circles. a, b were generated using Pymol (Schrödinger LLC). c was generated using Biorender.com
Fig. 2
Fig. 2. KCa2.3 channel structure and GOF mutations.
a Human KCa2.3 channel homology model generated using human KCa3.1 channel (PDB: 6cnn) as a template. Pore-forming channel α-subunits are shown in pale blue and its accessory CaM is shown in gray. Mutations are shown as spheres with carbon atoms in magenta, oxygen atoms in red and nitrogen atoms in dark blue. Mutations in only one of the four α-subunits are shown for clarity. In the inset, the relative position of CaM N-lobe, the S4-S5 linker (S45A and S45B helices), and HA helix are shown. b Mutations in the transmembrane S6 domain of channel pore. Mutations in only one of two opposite α-subunits are shown for clarity. c Schematic representation of one KCa2.3 channel subunit. Pathogenic GOF mutations are shown as red circles. a, b were generated using Pymol (Schrödinger LLC). c was generated using Biorender.com
Fig. 3
Fig. 3. KCa3.1 channel structure and GOF mutations.
a Human KCa3.1 channel cryo-EM structure (PDB: 6cnn). Pore-forming channel α-subunits are shown in pale green, and its accessory CaM is shown in gray. Mutations are shown as spheres with carbon atoms in magenta, oxygen atoms in red and nitrogen atoms in dark blue. Mutations in only one of the four α-subunits are shown for clarity. In the inset, the relative position of CaM C-lobe and HA/HB helices is shown. b The V282 residue defines the narrowest site of the cytoplasmic gate. c Schematic representation of one KCa3.1 channel subunit. Pathogenic GOF mutations are shown as red circles. a and b were generated using Pymol (Schrödinger LLC). c was generated using Biorender.com

Similar articles

Cited by

References

    1. Aldrich RW, Chandy KG, Grissmer S, Gutman GA, Kaczmarek LK, Wei AD, et al. Calcium- and sodium-activated potassium channels (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019.
    1. Xia XM, Fakler B, Rivard A, Wayman G, Johnson-Pais T, Keen JE, et al. Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature. 1998;395:503–7. doi: 10.1038/26758. - DOI - PubMed
    1. Brown BM, Shim H, Christophersen P, Wulff H. Pharmacology of small- and intermediate-conductance calcium-activated potassium channels. Annu Rev Pharmacol Toxicol. 2020;60:219–40.. doi: 10.1146/annurev-pharmtox-010919-023420. - DOI - PMC - PubMed
    1. Higham J, Sahu G, Wazen RM, Colarusso P, Gregorie A, Harvey BSJ, et al. Preferred formation of heteromeric channels between coexpressed SK1 and IKCa Channel subunits provides a unique pharmacological profile of Ca2+-activated potassium channels. Mol Pharmacol. 2019;96:115–26. doi: 10.1124/mol.118.115634. - DOI - PubMed
    1. Tuteja D, Rafizadeh S, Timofeyev V, Wang S, Zhang Z, Li N, et al. Cardiac small conductance Ca2+-activated K+ channel subunits form heteromultimers via the coiled-coil domains in the C termini of the channels. Circ Res. 2010;107:851–9. doi: 10.1161/CIRCRESAHA.109.215269. - DOI - PMC - PubMed

MeSH terms

Substances